Frontiers in Neurology (Jan 2019)

Extracranial and Intracranial Vasculopathy With “Moyamoya Phenomenon” in Association With Alagille Syndrome

  • Siobhan Delaney,
  • Siobhan Delaney,
  • Ged O'Connor,
  • William Reardon,
  • Stephen J. X. Murphy,
  • Stephen J. X. Murphy,
  • Stephen J. X. Murphy,
  • Sean Tierney,
  • Barbara M. Ryan,
  • Holly Delaney,
  • Colin P. Doherty,
  • Michael Guiney,
  • Paul Brennan,
  • W. Oliver Tobin,
  • W. Oliver Tobin,
  • W. Oliver Tobin,
  • Dominick J. H. McCabe,
  • Dominick J. H. McCabe,
  • Dominick J. H. McCabe,
  • Dominick J. H. McCabe,
  • Dominick J. H. McCabe,
  • Dominick J. H. McCabe

DOI
https://doi.org/10.3389/fneur.2018.01194
Journal volume & issue
Vol. 9

Abstract

Read online

Background: Alagille syndrome (AGS) is an autosomal-dominant, multisystem disorder caused by mutations in the JAG1 gene.Case Description: A 34-year-old man was referred to our service 10 years ago with focal seizures with impaired awareness and transient slurred speech. He had a 5-year history of intermittent left monocular low-flow retinopathy. He has a family history of AGS. General examination revealed mild hypertension, aortic regurgitation, and livedo reticularis. Neurological examination was normal.Investigations: He had mild hyperlipidaemia and persistently-positive lupus anticoagulant consistent with primary anti-phospholipid syndrome. Color Doppler ultrasound revealed low velocity flow in a narrowed extracranial left internal carotid artery (ICA). MR and CT angiography revealed a diffusely narrowed extracranial and intracranial left ICA. Formal cerebral angiography confirmed severe left ICA narrowing consistent with a left ICA “vasculopathy” and moyamoya phenomenon. Transthoracic echocardiogram revealed a bicuspid aortic valve and aortic incompetence. Molecular genetic analysis identified a missense mutation (A211P) in exon 4 of the JAG1 gene, consistent with AGS.Discussion: AGS should be considered in young adults with TIAs/stroke and unexplained extracranial or intracranial vascular abnormalities, and/or moyamoya phenomenon, even in the absence of other typical phenotypic features. Gene panels should include JAG1 gene testing in similar patients.

Keywords